Doriana Sorina Lupea-Chilom

Mrs. Doriana Sorina Lupea-Chilom

Dermatology, Victor Babeș University of Medicine and Pharmacy Timișoara, Timişoara, Timiş, Romania
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2023 in Medicina
Verified
Journal Article
Open access
PDF file
Doriana Sorina Lupea-ChilomDoriana Sorina Lupea-Chilom
Doriana Sorina Lupea-Chilom
CSCaius Silviu Solovan
Caius Silviu Solovan
SFSimona Sorina Farcaș
Simona Sorina Farcaș
Armand GogulescuArmand Gogulescu
Armand Gogulescu
NANicoleta Andreescu
Nicoleta Andreescu
Background and Objectives: Psoriasis is a chronic and inflammatory condition that has a huge impact on the patient’s quality of life. Biological treatment improved psoriasis therapy, with impressive results seen in the evolution of the disease and the patient’s quality of life. However, the risk of mycobacterium tuberculosis (MTB) infection reactivation is well-known to biological therapy, which raises problems especially in an endemic country. Materials and Methods: In this study, we followed moderate to severe psoriasis patients who had latent tuberculosis infection (LTBI) following treatment with a biological therapy approved in Romania. Results: The patients were evaluated at baseline and then followed-up with Mantoux tests and chest X-rays every year, resulting in 54 patients being diagnosed with LTBI. At the initial evaluation, 30 patients with LTBI were identified, and 24 more were identified during biological therapy. These patients were given prophylactic treatment. Out of the 97 participants in this retrospective study, 25 required association of methotrexate (MTX) alongside biological therapy. We compared the prevalence of positive Mantoux tests in patients with combined therapy with that of patients only on biological treatment, and the results were higher in the combined therapy group. Conclusion: All the patients in the study were vaccinated against tuberculosis (TB) after birth, and none were diagnosed with active tuberculosis (aTB) before or after the start of therapy according to the pulmonologist.

9 December 2022 in Life
Verified
Journal Article
Open access
PDF file
Doriana Sorina Lupea-ChilomDoriana Sorina Lupea-Chilom
Doriana Sorina Lupea-Chilom
SFSimona Sorina Farcaș
Simona Sorina Farcaș
NANicoleta Andreescu
Nicoleta Andreescu
The existence of two sequential lymphomas, one localized and one systemic, either both with B or T lymphocytes, or one with B cells and one with T cells, with the same patient, is a known possibility. The second lymphoma is often induced by immunodepression or by the initial treatment. However, the existence of two cutaneous lymphomas with different cell lines, without systemic involvement, represents an uncommon situation. In this report, we describe the case of a 37-year-old man with an initial diagnosis of PMZBCL that over 10 months also developed a MF patch/plaque on the left leg.

9 March 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Doriana Sorina Lupea-ChilomDoriana Sorina Lupea-Chilom
Doriana Sorina Lupea-Chilom
SFSimona Sorina Farcaș
Simona Sorina Farcaș
LPLaura Claudia Popa
Laura Claudia Popa
ATAnca Tudor
Anca Tudor
NANicoleta Andreescu
Nicoleta Andreescu
In recent years, genetic studies have brought new insights into psoriasis, a chronic inflammatory disease with multiple determining and favoring factors. Recent advances in the technology of genetic analysis have enabled the discovery of many loci with causal or susceptibility roles and the finding of correlations related to different types of treatment responses. In this study, genomic deoxyribonucleic acid (DNA) was extracted from 2 mL peripheral blood for the evaluation of rs10204525 for Programmed Cell Death 1 (PDCD1) gene and rs550675 for Collagen Type IX Alpha 1 Chain (COL9A1) gene in 45 psoriasis patients and 43 healthy subjects without a personal pathological history of dermatological diseases. All patients were diagnosed by clinical and histopathological examination, and the severity of disease and its impact on quality of life were evaluated by Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI) scores. Comparisons were made between controls and patients, but also between different clinical types of psoriasis according to disease severity. The rank of C/T alleles for rs550675 (COL9A1 gene) was higher in the patients versus the control group (p = 0.026), while the G/A alleles for rs10204525 (PDCD1 gene) had no differences between the two groups (p = 0.450). Case and control comparisons also showed statistical significance between homozygous CC/TT genotypes (p = 0.039). After subdividing the three types of psoriasis (plaque psoriasis, arthropathic psoriasis and palmoplantar psoriasis) according to disease severity, there were differences between CC/CT genotype (p = 0.0246) and CC/TT (p = 0.007) genotype in patients with plaque psoriasis in favor of severe disease. At the same time, the GA/GG versus AA pattern was significantly higher in patients with plaque psoriasis.